Lower Doses of Rituxan Equally Effective at Controlling AAV, Study Suggests
News
Lower doses of Rituxan (rituximab) appear to be as safe and effective as the standard Rituxan regimen for inducing remission in ANCA-associated vasculitis (AAV) patients, a retrospective Japanese study suggests. ... Read more